Creative Planning’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.24M | Buy |
99,354
+14,055
| +16% | +$979K | ﹤0.01% | 1020 |
|
|
2025
Q4 | $5.66M | Buy |
85,299
+9,949
| +13% | +$643K | ﹤0.01% | 920 |
|
|
2025
Q3 | $5.07M | Sell |
75,350
-1,880
| -2% | -$149K | ﹤0.01% | 877 |
|
|
2025
Q2 | $6.74M | Buy |
77,230
+3,713
| +5% | +$291K | 0.01% | 659 |
|
|
2025
Q1 | $5.02M | Buy |
73,517
+2,279
| +3% | +$186K | ﹤0.01% | 705 |
|
|
2024
Q4 | $5.54M | Buy |
71,238
+11,665
| +20% | +$864K | 0.01% | 630 |
|
|
2024
Q3 | $3.99M | Buy |
59,573
+10,880
| +22% | +$893K | ﹤0.01% | 729 |
|
|
2024
Q2 | $5.52M | Buy |
48,693
+2,271
| +5% | +$287K | 0.01% | 575 |
|
|
2024
Q1 | $6.44M | Buy |
46,422
+6,148
| +15% | +$773K | 0.01% | 533 |
|
|
2023
Q4 | $5M | Buy |
40,274
+2,416
| +6% | +$247K | 0.01% | 566 |
|
|
2023
Q3 | $3.53M | Buy |
37,858
+1,079
| +3% | +$122K | ﹤0.01% | 632 |
|
|
2023
Q2 | $4.73M | Buy |
36,779
+2,204
| +6% | +$267K | 0.01% | 539 |
|
|
2023
Q1 | $4.02M | Buy |
34,575
+2,038
| +6% | +$228K | 0.01% | 560 |
|
|
2022
Q4 | $3.68M | Buy |
32,537
+3,952
| +14% | +$434K | 0.01% | 554 |
|
|
2022
Q3 | $2.3M | Buy |
28,585
+2,827
| +11% | +$239K | ﹤0.01% | 656 |
|
|
2022
Q2 | $1.92M | Buy |
25,758
+1,446
| +6% | +$132K | ﹤0.01% | 730 |
|
|
2022
Q1 | $3.11M | Buy |
24,312
+4,296
| +21% | +$470K | ﹤0.01% | 586 |
|
|
2021
Q4 | $2.69M | Buy |
20,016
+352
| +2% | +$50.6K | ﹤0.01% | 600 |
|
|
2021
Q3 | $2.69M | Sell |
19,664
-3,372
| -15% | -$425K | ﹤0.01% | 591 |
|
|
2021
Q2 | $2.46M | Buy |
23,036
+1,684
| +8% | +$162K | ﹤0.01% | 604 |
|
|
2021
Q1 | $1.92M | Sell |
21,352
-11,816
| -36% | -$1.11M | ﹤0.01% | 752 |
|
|
2020
Q4 | $3.07M | Sell |
33,168
-7,632
| -19% | -$681K | 0.01% | 510 |
|
|
2020
Q3 | $4.21M | Sell |
40,800
-112
| -0.3% | -$11.7K | 0.01% | 343 |
|
|
2020
Q2 | $4.15M | Buy |
40,912
+5,768
| +16% | +$516K | 0.01% | 317 |
|
|
2020
Q1 | $2.37M | Buy |
35,144
+2,120
| +6% | +$132K | 0.01% | 384 |
|
|
2019
Q4 | $1.81M | Sell |
33,024
-1,640
| -5% | -$77.8K | 0.01% | 550 |
|
|
2019
Q3 | $1.29M | Buy |
34,664
+1,096
| +3% | +$42.6K | ﹤0.01% | 652 |
|
|
2019
Q2 | $1.26M | Sell |
33,568
-8,216
| -20% | -$258K | ﹤0.01% | 672 |
|
|
2019
Q1 | $1.24M | Buy |
41,784
+2,048
| +5% | +$72K | ﹤0.01% | 638 |
|
|
2018
Q4 | $1.19M | Sell |
39,736
-2,128
| -5% | -$67.5K | ﹤0.01% | 608 |
|
|
2018
Q3 | $1.5M | Buy |
41,864
+2,636
| +7% | +$81.7K | 0.01% | 575 |
|
|
2018
Q2 | $931K | Sell |
39,228
-1,420
| -3% | -$30.1K | ﹤0.01% | 780 |
|
|
2018
Q1 | $754K | Buy |
+40,648
| New | +$601K | ﹤0.01% | 877 |
|
|
2017
Q3 | – | Sell |
-1,888
| Closed | -$35K | – | 2354 |
|
|
2017
Q2 | $35K | Buy |
1,888
+368
| +24% | +$6.8K | ﹤0.01% | 2793 |
|
|
2017
Q1 | $32K | Hold |
1,520
| – | – | ﹤0.01% | 2787 |
|
|
2016
Q4 | $23K | Buy |
1,520
+140
| +10% | +$2.48K | ﹤0.01% | 2980 |
|
|
2016
Q3 | $30K | Buy |
1,380
+1,148
| +495% | +$25.6K | ﹤0.01% | 2729 |
|
|
2016
Q2 | $5K | Hold |
232
| – | – | ﹤0.01% | 3627 |
|
|
2016
Q1 | $4K | Sell |
232
-1,588
| -87% | -$26.5K | ﹤0.01% | 3685 |
|
|
2015
Q4 | $37K | Buy |
1,820
+152
| +9% | +$3.16K | ﹤0.01% | 2356 |
|
|
2015
Q3 | $36K | Buy |
+1,668
| New | +$37.2K | ﹤0.01% | 2294 |
|
|
2015
Q2 | – | Sell |
-1,400
| Closed | -$22K | – | 1588 |
|
|
2015
Q1 | $22K | Buy |
+1,400
| New | +$21.2K | ﹤0.01% | 2638 |
|
Other funds holding DXCM
VCM
VPM
Creative Planning's DXCM Position: Q1 2026 in Review
Creative Planning increased its DexCom (DXCM) stake by 16% in Q1 2026, buying an estimated $979K and bringing the position to 99,354 shares worth $6.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1020.
Creative Planning first reported a position in DXCM in Q1 2015 and has held it in 42 quarters since. The position peaked at $6.74M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Creative Planning held 99,354 shares of DexCom worth $6.24M as of Q1 2026.
- Creative Planning bought 14,055 DexCom shares in Q1 2026, an estimated $979K.
- DexCom made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #1020 holding.
- Creative Planning first reported a position in DexCom in Q1 2015 and has held it in 42 quarters since.
- Creative Planning's DexCom position peaked at $6.74M in Q2 2025.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.